Home › Trial NCT00102726
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
- Trial IDNCT00102726
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorGlaxoSmithKline
- Enrollment183
- Start date2005-02
- ConditionsThrombocytopaenia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.